![](/img/cover-not-exists.png)
Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen
Jacobus, S J, Rajkumar, S V, Weiss, M, Stewart, A K, Stadtmauer, E A, Callander, N S, Dreosti, L M, Lacy, M Q, Fonseca, RVolume:
6
Language:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/bcj.2016.55
Date:
July, 2016
File:
PDF, 176 KB
english, 2016